ATE467128T1 - Kolloidale metallkonjugate - Google Patents
Kolloidale metallkonjugateInfo
- Publication number
- ATE467128T1 ATE467128T1 AT06739848T AT06739848T ATE467128T1 AT E467128 T1 ATE467128 T1 AT E467128T1 AT 06739848 T AT06739848 T AT 06739848T AT 06739848 T AT06739848 T AT 06739848T AT E467128 T1 ATE467128 T1 AT E467128T1
- Authority
- AT
- Austria
- Prior art keywords
- colloidal metal
- metal conjugates
- conjugates
- quantitative
- samples
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
- A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Ceramic Engineering (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Nanotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Chemically Coating (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66585105P | 2005-03-29 | 2005-03-29 | |
PCT/US2006/011323 WO2006105111A2 (en) | 2005-03-29 | 2006-03-28 | Colloidal metal conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE467128T1 true ATE467128T1 (de) | 2010-05-15 |
Family
ID=37054025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06739848T ATE467128T1 (de) | 2005-03-29 | 2006-03-28 | Kolloidale metallkonjugate |
Country Status (6)
Country | Link |
---|---|
US (1) | US8232045B2 (de) |
EP (1) | EP1869468B1 (de) |
CN (1) | CN101151532B (de) |
AT (1) | ATE467128T1 (de) |
DE (1) | DE602006014120D1 (de) |
WO (1) | WO2006105111A2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8777875B2 (en) * | 2008-07-23 | 2014-07-15 | Otismed Corporation | System and method for manufacturing arthroplasty jigs having improved mating accuracy |
US8039272B2 (en) * | 2009-04-01 | 2011-10-18 | Nova Biomedical | Rapid quantification assay involving concentrated and ligand-coated gold colloid |
JP2013511530A (ja) * | 2009-11-17 | 2013-04-04 | アバクシス, インコーポレイテッド | ライム病抗体の検出のためのペプチドおよび方法 |
WO2011129220A1 (ja) | 2010-04-14 | 2011-10-20 | 日東紡績株式会社 | 試料中の分析対象物質を測定するための検査器具及びそれを用いた分析対象物質の測定方法 |
US8758772B2 (en) | 2011-11-04 | 2014-06-24 | Abaxis, Inc. | Peptides and methods for the detection of lyme disease antibodies |
CN103901195B (zh) * | 2014-03-27 | 2016-01-20 | 云南省烟草农业科学研究院 | 一种检测烟草花叶病毒的胶体金免疫层析试纸及其制备方法 |
CN111821316A (zh) * | 2019-04-19 | 2020-10-27 | 北京大学 | 用于免疫增强的锰组合物 |
CN112691120B (zh) * | 2019-10-23 | 2022-03-29 | 北京大学 | 二价锰在制备免疫增强药物或抗肿瘤药物中的应用 |
CN114740192B (zh) * | 2022-04-21 | 2025-03-11 | 郑州凌思生物科技有限责任公司 | 一种高浓度胶体金的标记方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7807532A (nl) * | 1978-07-13 | 1980-01-15 | Akzo Nv | Metaal-immunotest. |
US5120643A (en) * | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
US4859612A (en) * | 1987-10-07 | 1989-08-22 | Hygeia Sciences, Inc. | Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite |
AU2684488A (en) * | 1988-06-27 | 1990-01-04 | Carter-Wallace, Inc. | Test device and method for colored particle immunoassay |
US5252496A (en) * | 1989-12-18 | 1993-10-12 | Princeton Biomeditech Corporation | Carbon black immunochemical label |
-
2006
- 2006-03-28 CN CN200680010431XA patent/CN101151532B/zh active Active
- 2006-03-28 WO PCT/US2006/011323 patent/WO2006105111A2/en active Application Filing
- 2006-03-28 AT AT06739848T patent/ATE467128T1/de not_active IP Right Cessation
- 2006-03-28 US US11/887,145 patent/US8232045B2/en active Active
- 2006-03-28 EP EP06739848A patent/EP1869468B1/de active Active
- 2006-03-28 DE DE602006014120T patent/DE602006014120D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
EP1869468A4 (de) | 2009-03-04 |
WO2006105111A2 (en) | 2006-10-05 |
CN101151532A (zh) | 2008-03-26 |
EP1869468B1 (de) | 2010-05-05 |
WO2006105111B1 (en) | 2007-03-29 |
US20100015636A1 (en) | 2010-01-21 |
CN101151532B (zh) | 2012-12-12 |
EP1869468A2 (de) | 2007-12-26 |
WO2006105111A3 (en) | 2007-02-08 |
US8232045B2 (en) | 2012-07-31 |
DE602006014120D1 (de) | 2010-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE467128T1 (de) | Kolloidale metallkonjugate | |
ATE519863T1 (de) | Nicht-fluoreszente energieübertragung | |
SV2007002227A (es) | Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina ref. 040000-0317637 | |
ES2525330T3 (es) | Uso de sulfato de condroitina para reducir la unión no específica en inmunoensayos de troponina I | |
CY1117721T1 (el) | Κυτταρα προελευσης αμνιακου υγρου | |
DE602006017365D1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
HN2008001104A (es) | Compuestos para anticuerpos de dickpf-1 y70-4 | |
DE60114016D1 (de) | Elektrochemischer immunoassay mit kolloidalem metall | |
CU23809A3 (es) | Anticuerpo específico prlr | |
DK1864129T3 (da) | Doxurubicin-immunassay | |
MA30922B1 (fr) | Anticorps d'agonistes de trkb et leurs utilisations | |
EP2302382A3 (de) | Docetaxel Konjugaten und Immunogenen zur Verwendung in einem Immunassay | |
ATE550354T1 (de) | Humane ringspezifische bnp-antikörper | |
BRPI0607323B8 (pt) | composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo | |
EA200702361A1 (ru) | АНТИТЕЛА ПРОТИВ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ | |
NO20083593L (no) | Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse | |
MX2020006728A (es) | Metodos para medir analito y/o proteina en muestras biologicas. | |
BR0309841B1 (pt) | dispositivo para o recolhimento de amostra de amostras lìquidas. | |
SG171630A1 (en) | Protein detection reagents and methods with dyes and dextrins | |
BRPI0517647A (pt) | combinações de agonistas do receptor nicotìnico alfa 7 de acetilcolina | |
DK1951395T3 (da) | Fremgangsmåde til kvantitativ bestemmelse af poloxamerer | |
WO2007051603A3 (en) | Kit comprising 2, 4- dichlorophenoxyacetic acd derivatives and antibodies for highly sensitive detection assays | |
MX2007013108A (es) | Reactivos que enlazan ccx-ckr2. | |
DE60222091D1 (de) | Dendritische chemilumineszierende Substrate | |
ATE529749T1 (de) | Chromatographische teststreifen für ein oder mehrere analyte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |